The Global En Bloc Resection of Bladder Tumour Registry
Recruiting
Observational Study
Bladder Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 2,000 (estimated)
- Sponsor
- Chinese University of Hong Kong · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The study aims to collect data on ERBT globally in order to clarify its role in the management of bladder cancer over a 5-year observation period.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult patients \>=18 years old with informed consent
* Presence of bladder tumour undergoing transurethral ERBT
Exclusion Criteria:
* Presence or previous history of upper tract urothelial carcinoma
* Presence of other active malignancy
* Pregnancy
Contacts